Beximco Pharmaceuticals Limited
BXP.L · LSE
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £2 | £1 | £1 | £1 |
| Short-Term Investments | £1 | £0 | £0 | £0 |
| Receivables | £5 | £7 | £6 | £4 |
| Inventory | £15 | £14 | £13 | £14 |
| Other Curr. Assets | £3 | £0 | £0 | £3 |
| Total Curr. Assets | £25 | £23 | £21 | £22 |
| Property Plant & Equip (Net) | £44 | £43 | £43 | £43 |
| Goodwill | £1 | £1 | £1 | £1 |
| Intangibles | £5 | £5 | £5 | £5 |
| Long-Term Investments | -£1 | -£0 | -£0 | -£0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £1 | £0 | £0 | £0 |
| Total NC Assets | £49 | £48 | £49 | £48 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £74 | £71 | £69 | £70 |
| Liabilities | – | – | – | – |
| Payables | £3 | £4 | £4 | £5 |
| Short-Term Debt | £4 | £2 | £3 | £6 |
| Tax Payable | £1 | £1 | £0 | £1 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £3 | £3 | £2 | £1 |
| Total Curr. Liab. | £12 | £9 | £10 | £12 |
| LT Debt | £2 | £0 | £2 | £2 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £3 | £3 | £3 | £0 |
| Other NC Liab. | £4 | £5 | £4 | £6 |
| Total NC Liab. | £9 | £8 | £8 | £8 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £20 | £17 | £17 | £20 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £4 | £4 | £4 | £4 |
| Retained Earnings | £37 | £37 | £35 | £34 |
| AOCI | £1 | £1 | £1 | £1 |
| Other Equity | £7 | £7 | £7 | £7 |
| Total Equity | £50 | £50 | £48 | £46 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £4 | £4 | £4 | £4 |
| Total Liab. & Tot. Equity | £74 | £71 | £69 | £70 |
| Net Debt | £5 | £1 | £4 | £6 |